Genetic Counseling for Families With Inherited Susceptibility to Breast and Ovarian Cancer

JAMA: The Journal of the American Medical Association

Volumn 269, Issue 15, 1993, Pages 1970-1974

  Biesecker, Barbara B ^a,b   Boehnke, Michael ^b   Calzone, Kathy ^a   Markel, Dorene S ^a,b   Garber, Judy E ^d   Collins, Francis S ^a,b,c   Weber, Barbara L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 17Q; FEMALE; GENE ISOLATION; GENE MUTATION; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; OVARY CANCER; PRIORITY JOURNAL;

BREAST NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMAN; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; SOCIAL SUPPORT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027465404     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03500150082032     Document Type: Article

References (28)

1. Hall JM, Lee MK, Newman B, et al. Linkage of early onset breast cancer to chromosome 17q21. Science. 1990;250:1684-1689.
2. Narod SA, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet. 1991;338:82-83.
3. Lynch HT, Watson P. Genetic counselling and hereditary breast/ovarian cancer. Lancet. 1992;339: 1181.
4. Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer— results from 214 families. Am J Hum Genet. In press.
5. Arason A, Barkardottir RB, Egilsson V. Linkage analysis of chromosome 17 markers and breast-ovarian cancer in Icelandic families and possible relationship to prostatic cancer. Am J Hum Genet. In press.
6. Leone A, McBride W, Weston A, et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res. 1991;51:2490-2493.
7. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res. 1991;51:5794-5799.
8. Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci USA. 1990;87:7737-7741.
9. Collins FS. Positional cloning: let’s not call it reverse anymore. Nature Genet. 1992;1:3-6.
10. Collins FS. Medical and ethical consequences of the human genome project. J Clin Ethics. 1991;2:260-267.
11. Guidelines for Predictive Testing for Huntington’s Disease. New York, NY: The Huntington’s Disease Society of America; 1989.
12. Hannig VL, Hopkins JR, Johnson HK, et al. Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors. Am J Med Genet. 1991;40:425-428.
13. National Kidney Foundation Scientific Advisory Board. Gene testing in autosomal dominant polycystic kidney disease: results of National Kidney Foundation Workshop. Am J Kidney Dis. 1989;13:85-87.
14. Rosen P. International Conference on Risk-Adapted Adjuvant Therapy in Breast Cancer; February 29, 1992; St Gallen, Switzerland.
15. Chamberlain JS, Boehnke M, Frank TS, et al. Further narrowing of the BRCA1 region on chromosome 17q12-21 by genetic analysis. Am J Hum Genet. In press.
16. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet. 1955;7:277-318.
17. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER and dGENE. Genet Epidemiol. 1988;5:471-472.
18. White R. Chromosome 17 Workshop; March 13-14, 1992; Park City, Utah.
19. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet. 1991;48:232-242.
20. Bloch M, Hayden MR. Opinion: predictive testing for Huntington disease in childhood: challenges and implications. Am J Hum Genet. 1990;46:1-4.
21. Huggins M, Bloch M, Kanani S, et al. Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease. Am J Hum Genet. 1990;47:4-12.
22. Wiggins S, Whyte P, Huggins M, et al. The psychological consequences of predictive testing for Huntington’s disease. N Engl J Med. 1992;327:1401-1405.
23. Quaid K. Presymptomatic testing for Huntington disease: recommendations for counseling. J Genet Counsel. 1992;1:277-302.
24. Chapman MA. Predictive testing for adult-onset genetic disease: ethical and legal implications of the use of linkage analysis for Huntington disease. Am J Hum Genet. 1990;47:1-3.
25. Li FP, Garber JE, Friend SH, et al. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992;84:1156-1160.
26. Li FP, Fraumeni JF. Predictive testing for inherited mutations in cancer-susceptibility genes. J Clin Oncol. 1992;10:1203-1204.
27. Billings PR, Kohn MA, de Cuevas M. Discrimination as a consequence of genetic testing. Am J Hum Genet. 1992;50:476-482.
28. McEwen JE, McCarty K, Reilly PR. A survey of state insurance commissioners concerning genetic testing and life insurance. Am J Hum Genet. 1992;51:785-792.